VCYT

NASDAQ · Biotechnology

Veracyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$31.84

-0.94 (-2.87%)

As of Mar 22, 9:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 79%

Hold 3 16%

Sell 1 5%

Price Target

Analyst Price Target +47.1% upside

Low Target $30.44

Average Target $46.85

High Target $57.64

Current Price $31.84

Current
$31.84

Target
$46.85

$30.44 $46.85 avg $57.64

Scenario Analysis

Bear Case

$30.44

-4.4%

Low target

Base Case

$46.85

+47.1%

Avg target

Bull Case

$57.64

+81.0%

High target

Risk/Reward

18.4x

Highly favorable

Price in Context

52-Week High

$50.71

-37.2% from high

52-Week Low

$22.61

+40.8% from low

50-Day SMA

$40.85

-22.1% vs SMA

200-Day SMA

$34.09

-6.6% vs SMA

RSI (14)

37.6

Neutral

Target vs 52W High

$46.85

-7.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%